Bicarb vs. Insulin Resistance

Bicarb vs. Insulin Resistance

pHAlo™ was created for pH balance and optimal health. It can be used for people who are at risk for type 2 diabetes mellitus, diabetes or other chronic diseases.

Insulin resistance leads to uncontrolled blood sugar levels which may lead to type 2 diabetes. The National Health and Nutrition Examination Survey studied 1,496 adults without diabetes or other chronic diseases and found that lower bicarbonate levels and higher anion gap (acidosis) are independently associated with insulin resistance.

A low saliva pH (too much acid) has been shown to be a predictor in insulin resistance and obesity that may result in metabolic syndrome. Metabolic syndrome is a number of interrelated clinical disorders that include obesity, high blood sugar, insulin resistance, high cholesterol, high blood pressure, inflammation, and increased bad cholesterol levels. Especially at risk for metabolic syndrome are perimenopausal and postmenopausal women.

In another study by CMAJ.2012 Sep 18;184{13);E719-725 plasma bicarbonate and the risk of type 2 diabetes mellitus was studied. 630 women who did not have type 2 diabetes mellitus at the time of the study were examined. The results of this study revealed higher plasma bicarbonate levels (less acid) were associated with decreased incidence of type 2 diabetes among these women.

Resistance to insulin is central to the development of type 2 diabetes mellitus. Several mechanisms may lead to insulin resistance and thereby contribute to the development of type 2 DM, including fatty acid metabolism, mitochondrial dyfunction and systemic inflammation. Metabolic acidosis may also contribute to insulin resistance. Mild metabolic acidosis reduces tissue insulin sensitivity. Finally, metabolic acidosis may also increase cortisol production, which in turn is implicated in the development of insulin resistance.

You can read these facts and more at the National Center for Biotechnology Information and BMC Oral Health:

LIKE US on Facebook!